Rational engineering of the levanbiose-binding site in Erwinia tasmaniensis levansucrase effectively blocks levan polymerization, enabling high-yield production of bioactive LFOS.
Charoenwongpaiboon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: